vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and SHOE CARNIVAL INC (SCVL). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $297.2M, roughly 1.6× SHOE CARNIVAL INC). SHOE CARNIVAL INC runs the higher net margin — 4.9% vs -10.1%, a 15.0% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -3.2%). SHOE CARNIVAL INC produced more free cash flow last quarter ($19.7M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 3.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Shoe Carnival Inc. is an American retailer of family footwear. The company operates 429 stores throughout the midwest, south, and southeast regions, and Puerto Rico. It was founded by David Russell in 1978 and is headquartered in Fort Mill, South Carolina as of 2025.

CLOV vs SCVL — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.6× larger
CLOV
$487.7M
$297.2M
SCVL
Growing faster (revenue YoY)
CLOV
CLOV
+47.9% gap
CLOV
44.7%
-3.2%
SCVL
Higher net margin
SCVL
SCVL
15.0% more per $
SCVL
4.9%
-10.1%
CLOV
More free cash flow
SCVL
SCVL
$88.7M more FCF
SCVL
$19.7M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
3.0%
SCVL

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
SCVL
SCVL
Revenue
$487.7M
$297.2M
Net Profit
$-49.3M
$14.6M
Gross Margin
37.6%
Operating Margin
-10.1%
6.3%
Net Margin
-10.1%
4.9%
Revenue YoY
44.7%
-3.2%
Net Profit YoY
-123.2%
-23.9%
EPS (diluted)
$0.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SCVL
SCVL
Q4 25
$487.7M
$297.2M
Q3 25
$496.6M
$306.4M
Q2 25
$477.6M
$277.7M
Q1 25
$462.3M
$262.9M
Q4 24
$337.0M
$306.9M
Q3 24
$331.0M
$332.7M
Q2 24
$356.3M
$300.4M
Q1 24
$346.9M
$280.2M
Net Profit
CLOV
CLOV
SCVL
SCVL
Q4 25
$-49.3M
$14.6M
Q3 25
$-24.4M
$19.2M
Q2 25
$-10.6M
$9.3M
Q1 25
$-1.3M
$14.7M
Q4 24
$-22.1M
$19.2M
Q3 24
$-9.2M
$22.6M
Q2 24
$7.4M
$17.3M
Q1 24
$-19.2M
$15.5M
Gross Margin
CLOV
CLOV
SCVL
SCVL
Q4 25
37.6%
Q3 25
38.8%
Q2 25
34.5%
Q1 25
34.9%
Q4 24
36.0%
Q3 24
24.5%
36.1%
Q2 24
30.3%
35.6%
Q1 24
23.6%
35.6%
Operating Margin
CLOV
CLOV
SCVL
SCVL
Q4 25
-10.1%
6.3%
Q3 25
-4.9%
8.2%
Q2 25
-2.2%
4.3%
Q1 25
-0.3%
5.3%
Q4 24
-6.4%
8.0%
Q3 24
-2.7%
9.0%
Q2 24
2.0%
7.5%
Q1 24
-6.5%
7.1%
Net Margin
CLOV
CLOV
SCVL
SCVL
Q4 25
-10.1%
4.9%
Q3 25
-4.9%
6.3%
Q2 25
-2.2%
3.4%
Q1 25
-0.3%
5.6%
Q4 24
-6.6%
6.3%
Q3 24
-2.8%
6.8%
Q2 24
2.1%
5.8%
Q1 24
-5.5%
5.5%
EPS (diluted)
CLOV
CLOV
SCVL
SCVL
Q4 25
$0.53
Q3 25
$0.70
Q2 25
$0.34
Q1 25
$0.53
Q4 24
$0.70
Q3 24
$0.82
Q2 24
$0.63
Q1 24
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SCVL
SCVL
Cash + ST InvestmentsLiquidity on hand
$78.3M
$107.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$683.2M
Total Assets
$541.0M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SCVL
SCVL
Q4 25
$78.3M
$107.7M
Q3 25
$91.9M
Q2 25
$93.0M
Q1 25
$123.1M
Q4 24
$194.5M
$91.1M
Q3 24
$288.0M
$84.5M
Q2 24
$254.8M
$69.5M
Q1 24
$208.3M
$111.2M
Stockholders' Equity
CLOV
CLOV
SCVL
SCVL
Q4 25
$308.7M
$683.2M
Q3 25
$340.9M
$670.7M
Q2 25
$344.2M
$653.6M
Q1 25
$336.1M
$649.0M
Q4 24
$341.1M
$635.7M
Q3 24
$342.2M
$618.5M
Q2 24
$324.9M
$597.8M
Q1 24
$292.5M
$583.4M
Total Assets
CLOV
CLOV
SCVL
SCVL
Q4 25
$541.0M
$1.2B
Q3 25
$559.7M
$1.2B
Q2 25
$575.0M
$1.1B
Q1 25
$583.7M
$1.1B
Q4 24
$580.7M
$1.1B
Q3 24
$653.0M
$1.1B
Q2 24
$674.2M
$1.1B
Q1 24
$671.8M
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SCVL
SCVL
Operating Cash FlowLast quarter
$-66.9M
$33.6M
Free Cash FlowOCF − Capex
$-69.0M
$19.7M
FCF MarginFCF / Revenue
-14.1%
6.6%
Capex IntensityCapex / Revenue
0.4%
4.7%
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$35.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SCVL
SCVL
Q4 25
$-66.9M
$33.6M
Q3 25
$12.1M
$13.3M
Q2 25
$5.4M
$-9.6M
Q1 25
$-16.3M
$44.5M
Q4 24
$34.8M
$17.3M
Q3 24
$50.0M
$23.7M
Q2 24
$44.8M
$17.1M
Q1 24
$25.9M
$53.4M
Free Cash Flow
CLOV
CLOV
SCVL
SCVL
Q4 25
$-69.0M
$19.7M
Q3 25
$11.4M
$2.2M
Q2 25
$4.8M
$-23.0M
Q1 25
$-16.5M
$36.2M
Q4 24
$33.3M
$8.3M
Q3 24
$49.6M
$18.2M
Q2 24
$44.4M
$6.9M
Q1 24
$25.5M
$40.7M
FCF Margin
CLOV
CLOV
SCVL
SCVL
Q4 25
-14.1%
6.6%
Q3 25
2.3%
0.7%
Q2 25
1.0%
-8.3%
Q1 25
-3.6%
13.8%
Q4 24
9.9%
2.7%
Q3 24
15.0%
5.5%
Q2 24
12.5%
2.3%
Q1 24
7.3%
14.5%
Capex Intensity
CLOV
CLOV
SCVL
SCVL
Q4 25
0.4%
4.7%
Q3 25
0.1%
3.6%
Q2 25
0.1%
4.8%
Q1 25
0.0%
3.2%
Q4 24
0.5%
3.0%
Q3 24
0.1%
1.7%
Q2 24
0.1%
3.4%
Q1 24
0.1%
4.5%
Cash Conversion
CLOV
CLOV
SCVL
SCVL
Q4 25
2.30×
Q3 25
0.69×
Q2 25
-1.03×
Q1 25
3.04×
Q4 24
0.90×
Q3 24
1.05×
Q2 24
6.04×
0.99×
Q1 24
3.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons